EMEA-002189-PIP01-17-M01

Key facts

Active substance
Bimekizumab
Therapeutic area
Dermatology
Decision number
P/0375/2019
PIP number
EMEA-002189-PIP01-17-M01
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Treatment of psoriasis
Route(s) of administration
Subcutaneous use
Contact for public enquiries
UCB Biopharma SPRL

Tel.  +44 1753777100
E-mail: UCBCares.UK@ucb.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating